Asston Pharmaceuticals IPO GMP: Price Band, Subscription & Listing Insights
The pharmaceutical sector continues to attract investor attention, and Asston Pharmaceuticals Limited is the latest SME company to join the IPO wave. With a focus on manufacturing and marketing pharmaceutical products, the company’s IPO is generating strong grey market interest. This blog covers all the essential aspects—from Asston Pharmaceuticals IPO GMP today to allotment and listing expectations.
About Asston Pharmaceuticals Limited
Asston Pharmaceuticals Limited is engaged in the development, manufacturing, and distribution of pharmaceutical formulations. The company has a growing product portfolio that includes tablets, capsules, ointments, and syrups catering to therapeutic areas like dermatology, pediatrics, and orthopedics.
Industry: Pharmaceuticals & Healthcare
Core Business: Generic drug manufacturing and B2B supply
Promoters: Mr. Ravi Patel & Mr. Mukesh Chaudhari
Market Reach: Pan-India with 100+ distributors
Certifications: WHO-GMP, ISO Certified
Asston Pharmaceuticals IPO Details
Here is a quick summary of the IPO:
Parameter | Details |
IPO Name | Asston Pharmaceuticals Limited IPO |
IPO Type | SME IPO |
Exchange | NSE SME |
IPO Open Date | July 10, 2025 |
IPO Close Date | July 15, 2025 |
Price Band | ₹78 – ₹82 per share |
Lot Size | 1,600 shares |
Minimum Investment | ₹1,31,200 (at upper price band) |
Issue Size | ₹23.5 Crores (Fresh Issue) |
Face Value | ₹10 per share |
Allotment Date | July 16, 2025 |
Listing Date (Tentative) | July 19, 2025 |
Registrar | Bigshare Services Pvt. Ltd. |
Use of Funds: Working capital, R&D investment, and general corporate purposes.
Asston Pharmaceuticals IPO GMP Today
The Asston Pharmaceuticals IPO GMP (Grey Market Premium) is one of the top indicators of investor sentiment. As per the current update:
Date | GMP (₹) | Estimated Listing Price (₹) |
July 8, 2025 | ₹28 – ₹30 | ₹110 – ₹112 |
July 9, 2025 | ₹31 – ₹33 | ₹113 – ₹115 |
July 10, 2025 | ₹33 – ₹35 | ₹115 – ₹117 |
The rising Asston Pharmaceuticals IPO GMP today signals strong demand and an expected premium of nearly 40% over the issue price.
Subscription Status (Live)
The IPO has witnessed strong investor interest, particularly from retail and HNI segments.
Investor Category | Day 1 | Day 2 | Final Day (Expected) |
Retail Individual Investors (RII) | 12.3× | 35.7× | 50×+ |
Non-Institutional Investors (NII) | 9.6× | 28.1× | 45×+ |
Total Subscription | 10.9× | 32.4× | 48–52× |
Company Financials Overview
Financial Metric | FY 2023 | FY 2024 (Provisional) |
Total Revenue | ₹18.2 Cr | ₹24.6 Cr |
EBITDA | ₹2.1 Cr | ₹3.6 Cr |
Profit After Tax | ₹1.4 Cr | ₹2.2 Cr |
Net Worth | ₹9.8 Cr | ₹12.3 Cr |
Debt-to-Equity | 0.42 | 0.35 |
RONW | 15.3% | 18.7% |